top of page

Analysis of G-Med Physician Posts and Comments on the Topic of Rheumatoid Arthritis

Topics/keywords: ‘rheumatoid arthritis’

Data types: posts, comments, likes, polls

Geographical segment: global physicians, physicians by region

Analyzed data points: 3,037

Specialties: Rheumatology, Allergy and Immunology, Internal Medicine

Countries analyzed: 60

Reach: 183,553

Introduction

This report presents a detailed analysis of physicians' discussions on the topic of rheumatoid arthritis, based on data collected from the G-Med platform. The report explores the primary concerns and opinions expressed by physicians regarding rheumatoid arthritis diagnosis, treatment, and care. Key insights have been gathered through sentiment analysis and statistical evaluation of the topics discussed, highlighting geographical differences and trends in medical approaches. A keyword-based approach identified recurring concerns, and statistics were likewise compiled from post interactions (views, comments, and likes). Contrasting opinions on various concerns (e.g., in favor vs. against) were quantified and presented as percentages.


The findings provide a comprehensive overview of the challenges, innovations, and regional preferences of G-Med physicians in regards to rheumatoid arthritis, shedding light on the sentiments and strategies favored by medical professionals.


Main Concerns of G-Med Physicians on the Topic of Rheumatoid Arthritis

Screenshot 2024-09-26 104230.png
  • Challenges in Diagnosis (26% of physician discussions): Physicians emphasize the difficulty of diagnosing rheumatoid arthritis (RA) in its early stages due to the overlap of symptoms with other autoimmune diseases.

    • 63% of discussions focus on the limitations of existing diagnostic tools, such as the variability of rheumatoid factor (RF) and anti-CCP tests.

    • 37% of discussions highlight the importance of clinical       examination and imaging techniques, like ultrasound or MRI, to supplement lab tests.

  • Treatment Efficacy and Accessibility (23%): Discussions frequently center on the efficacy of biologic and targeted synthetic disease-modifying antirheumatic drugs (DMARDs), such as TNF inhibitors and      JAK inhibitors.

    • 58% of physicians expressed positive sentiment about the long-term efficacy of these treatments.

    • 42% raised concerns about high costs and limited accessibility, especially in low-resource settings.

Screenshot 2024-09-26 104230.png

Screenshot 2024-09-26 104230.png
  • Management of Chronic Pain and Inflammation (20%): Chronic pain  management emerged as a significant concern.

    • 70% of discussions emphasized the role of NSAIDs and       corticosteroids in symptom relief.

    • The remaining 30% focused on alternative strategies like physical therapy, dietary changes, and patient education.

  • Monitoring and Patient Compliance (14%): Physicians discuss      challenges in ensuring patient compliance with prescribed treatments and follow-up plans.

46% of discussions highlight difficulties with adherence to long-term DMARD therapy, with 7.32% of discussions specifically focused on the side effects of DMARD therapy. Key concerns include issues such as adverse effects,drug tolerance, and toxicity, which contribute to reduced patient adherence and the need for close monitoring.

  • 54% of discussions touch on strategies like shared decision-making and education to improve compliance.

  • Psychological Impact and Patient Quality of Life (9%): Discussions shed light on the psychological toll of rheumatoid arthritis, including anxiety and depression caused by chronic pain and reduced mobility.

    • 62% of discussions on this topic advocate for integrating mental health support into rheumatoid arthritis care plans.

    • 38% express concern about the lack of accessible resources for mental health support.

Screenshot 2024-09-26 104230.png

Geographical Analysis of Physician Discussions:

Screenshot 2024-09-26 104230.png

Of the 60 countries analyzed, the following topics were discussed in prominent countries:

  • United States: Physicians focus heavily on  innovative biologic treatments and accessibility challenges due to cost.

  • United Kingdom: Discussions emphasize the      importance of early diagnosis and access to advanced imaging techniques      like ultrasound.

  • Germany: German physicians frequently discuss combination therapies and their role in achieving remission.

  • Canada: Patient education on self-management strategies and      monitoring flare-ups is a key focus.

  • France: Physicians in France highlight the psychological      impact of rheumatoid arthritis and advocate for integrating mental health      resources into standard care.

  • Australia: Discussions among Australian physicians focus on joint issues and peer consultations, highlighting the importance of physician collaboration and patient-oriented treatment approaches.

  • Turkey: Turkish physicians frequently discuss laboratory diagnostics, blood test interpretations, and inflammatory markers, emphasizing the role of clinical assessments in monitoring rheumatoid arthritis disease activity.

  • Argentina: Physicians in Argentina frequently discuss worsening eczema, facial rash, cellulitis, and pain symptoms, with a focus on differentiating between autoimmune and infectious causes of inflammatory conditions.

  • Brazil: Discussions in Brazil focus on affordable treatment options and challenges in accessing biologic DMARDs.

  • Japan: Japanese physicians discuss the cultural importance of adherence and patient education in managing rheumatoid arthritis effectively.

Screenshot 2024-09-26 104230.png

Engagement Recommendations:

Screenshot 2024-09-26 104230.png
  • As can be seen from the report, there are some knowledge gaps on the topic of rheumatoid arthritis, especially surrounding early diagnosis. An awareness campaign could be beneficial in this case, as well as a traffic-driving campaign in cases where there is a brand dot com.

  • G-Med's Awareness Package or Traffic-Driving Package could be a good fit here.

Screenshot 2024-09-26 104230.png

Screenshot 2024-09-26 104230.png
Screenshot 2024-09-26 104230.png
bottom of page